CompuGroup Medical SE & Co. KGaA (HAM:COP)
Germany · Delayed Price · Currency is EUR 27.50
0.00 (0.00%)
At close: Aug 14, 2026
HAM:COP Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,247 | 1,186 | 1,228 | 1,175 | 1,063 |
Other Revenue | 0.15 | 0.6 | 0.11 | 0.25 | 0.08 |
| 1,247 | 1,186 | 1,228 | 1,175 | 1,063 | |
Revenue Growth | 5.10% | -3.39% | 4.52% | 10.55% | 22.26% |
Cost of Revenue | 824.48 | 784.28 | 813.16 | 763.1 | 689.15 |
Gross Profit | 422.33 | 402.03 | 414.75 | 411.71 | 373.55 |
Selling, General & Admin | 10.83 | 12.01 | 11.85 | 11.63 | 10.78 |
Amortization of Goodwill & Intangibles | 64.73 | 66.81 | 64.51 | 69.21 | 66.72 |
Other Operating Expenses | 206.28 | 172.24 | 164.46 | 179.32 | 144.21 |
Operating Expenses | 334.6 | 304.11 | 292.09 | 313.14 | 266.92 |
Operating Income | 87.74 | 97.92 | 122.66 | 98.56 | 106.63 |
Interest Expense | -29.16 | -33.36 | -24.34 | -9.12 | -5.4 |
Interest & Investment Income | 1.66 | 1.32 | 1.06 | 0.81 | 0.72 |
Earnings From Equity Investments | 1.1 | -0.8 | 0.62 | -0.1 | 0.03 |
Currency Exchange Gain (Loss) | 0.59 | 0.02 | -2.94 | 1.08 | -0.39 |
Other Non Operating Income (Expenses) | -7.26 | -8.24 | -15.17 | 17.27 | 0.74 |
EBT Excluding Unusual Items | 54.66 | 56.85 | 81.9 | 108.51 | 102.34 |
Gain (Loss) on Sale of Assets | 0.17 | 5.85 | 1.04 | 0.16 | 1.69 |
Asset Writedown | - | -1.87 | -11.45 | -0.34 | -6.15 |
Other Unusual Items | 2.12 | -3.53 | 0.64 | -1.51 | 0 |
Pretax Income | 57.61 | 61.89 | 72.67 | 106.82 | 97.87 |
Income Tax Expense | 28.89 | 27.13 | 25.8 | 32.7 | 28.84 |
Earnings From Continuing Operations | 28.72 | 34.76 | 46.87 | 74.12 | 69.03 |
Net Income to Company | 28.72 | 34.76 | 46.87 | 74.12 | 69.03 |
Minority Interest in Earnings | -0.48 | -0.16 | -0.96 | -0.71 | -0.06 |
Net Income | 28.24 | 34.6 | 45.92 | 73.41 | 68.97 |
Net Income to Common | 28.24 | 34.6 | 45.92 | 73.41 | 68.97 |
Net Income Growth | -18.37% | -24.64% | -37.45% | 6.44% | -5.77% |
Shares Outstanding (Basic) | 52 | 52 | 52 | 52 | 53 |
Shares Outstanding (Diluted) | 52 | 53 | 52 | 52 | 53 |
Shares Change | -1.25% | 0.63% | 0.32% | -1.29% | 1.15% |
EPS (Basic) | 0.55 | 0.67 | 0.88 | 1.41 | 1.30 |
EPS (Diluted) | 0.54 | 0.66 | 0.88 | 1.40 | 1.30 |
EPS Growth | -18.18% | -24.92% | -37.21% | 7.69% | -7.14% |
Free Cash Flow | 125.79 | 104.08 | 160.56 | 119.18 | 138.23 |
Free Cash Flow Per Share | 2.41 | 1.97 | 3.06 | 2.28 | 2.61 |
Dividend Per Share | 0.500 | 0.050 | 1.000 | 0.500 | 0.500 |
Dividend Growth | 900.00% | -95.00% | 100.00% | 0% | 0% |
Gross Margin | 33.87% | 33.89% | 33.78% | 35.05% | 35.15% |
Operating Margin | 7.04% | 8.25% | 9.99% | 8.39% | 10.03% |
Profit Margin | 2.27% | 2.92% | 3.74% | 6.25% | 6.49% |
Free Cash Flow Margin | 10.09% | 8.77% | 13.08% | 10.14% | 13.01% |
EBITDA | 133.26 | 146.86 | 169.81 | 151.77 | 160.91 |
EBITDA Margin | 10.69% | 12.38% | 13.83% | 12.92% | 15.14% |
D&A For EBITDA | 45.52 | 48.94 | 47.15 | 53.2 | 54.28 |
EBIT | 87.74 | 97.92 | 122.66 | 98.56 | 106.63 |
EBIT Margin | 7.04% | 8.25% | 9.99% | 8.39% | 10.03% |
Effective Tax Rate | 50.15% | 43.84% | 35.50% | 30.61% | 29.47% |